DIASORIN ETI-MAK-2 PLUS ASSAY

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P990038 S005

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a revision in the assay package insert that incorporates a change in the interpretation algorithm for repeat testing results that make it the same as the interpretation for initial testing. "the user should apply the same interpretation of results (i. E. Reactive samples should have an absorbance value greater than 90% of the cutoff) when initial testing for some samples and repeat testing for other samples are performed on the same plate. "

DeviceDIASORIN ETI-MAK-2 PLUS ASSAY
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantDIASORIN, INC.
Date Received2003-07-16
Decision Date2003-08-20
PMAP990038
SupplementS005
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address DIASORIN, INC. 1951 Northwestern Ave. stillwater, MN 55082-0285

Supplemental Filings

Supplement NumberDateSupplement Type
P990038Original Filing
S032 2021-11-23 30-day Notice
S031 2020-07-16 30-day Notice
S030 2019-08-28 30-day Notice
S029 2019-06-18 30-day Notice
S028 2018-05-30 30-day Notice
S027 2018-03-30 30-day Notice
S026
S025 2018-02-14 30-day Notice
S024 2017-09-18 30-day Notice
S023 2017-04-25 30-day Notice
S022 2017-03-29 30-day Notice
S021 2016-05-10 30-day Notice
S020 2014-06-05 30-day Notice
S019 2013-12-27 30-day Notice
S018 2013-06-05 30-day Notice
S017 2012-11-09 Special (immediate Track)
S016
S015 2012-02-17 30-day Notice
S014 2011-10-18 30-day Notice
S013 2009-11-13 135 Review Track For 30-day Notice
S012 2009-11-13 Real-time Process
S011 2006-03-24 Special (immediate Track)
S010 2005-06-03 30-day Notice
S009
S008 2004-04-23 30-day Notice
S007 2004-04-05 30-day Notice
S006 2004-04-05 30-day Notice
S005 2003-07-16 Special (immediate Track)
S004 2002-10-29 Normal 180 Day Track
S003 2002-10-17 30-day Notice
S002 2002-01-16 Normal 180 Day Track
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.